JG
KZR

Jefferies Group’s Kezar Life Sciences KZR Stock Holding History

Jefferies Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$82.7K – 1801
2022
Q2 		$82.7K Buy
+1,000
New +$88.2K ﹤0.01% 1367
2022
Q1 		– Sell
-5,020
Closed -$839K – 1762
2021
Q4 		$839K Buy
+5,020
New +$567K ﹤0.01% 1051
2020
Q3 		– Sell
-50,040
Closed -$2.59K – 1459
2020
Q2 		$2.59K Buy
+50,040
New +$2.52M 0.03% 468

Other funds holding KZR

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Jefferies Group's KZR Position: Q3 2022 in Review

Jefferies Group sold out of Kezar Life Sciences (KZR) in Q3 2022, closing a stake of 1,000 shares — an estimated $82.7K sold.

Jefferies Group first reported a position in KZR in Q2 2020 and held it in 3 quarters. The position peaked at $839K in Q4 2021. 132 funds tracked by Wall St. Rank hold KZR as of Q3 2022.

  • Jefferies Group reported no remaining Kezar Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 1,000 Kezar Life Sciences shares in Q3 2022, an estimated $82.7K.
  • Jefferies Group first reported a position in Kezar Life Sciences in Q2 2020 and held it in 3 quarters.
  • Jefferies Group's Kezar Life Sciences position peaked at $839K in Q4 2021.
  • 132 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.